We recently published a list of Top 9 Healthcare Stocks to Buy According to Billionaire David Einhorn. In this article, we ...

LIMS_Market_1 LIMS market to grow from USD 2.93B in 2024 to USD 5B by 2035, driven by digital lab adoption and a projected 4.97% CAGR throu ...

Emerging research has uncovered disturbing links between diabetes during pregnancy and long-term neurodevelopmental outcomes ...

The integration of Artificial Intelligence (AI) in drug discovery is rapidly transforming the pharmaceutical industry.

KalVista's sebetralstat nears FDA approval as a first-in-class oral treatment for hereditary angioedema. Read here for an ...

Shortly after the publication of the report, Prabhjot Singh, M.D., senior adviser for strategic initiatives, at the Peterson Health Technology Institute, spoke with Healthcare Innovation ...

We recently published a list of Top 9 Healthcare Stocks to Buy According to Billionaire David Einhorn. In this article, we ...

When funding is tight, life sciences startups must be even more strategic with requested amounts, timing, and funding sources ...

Dexcom has been cash flow positive for since 2014 and more recently moved into positive earnings territory. While revenue has grown very quickly, research and development expenses and selling, general ...

The FDA announced a shift away from animal testing for drug approval, citing advanced alternatives like AI and organoids ...

The term „Unmet Need“ is used multiple times in EU HTA regulations, the EU pharmaceutical legislation and in HTA guidelines.

According to Source BioScience, the acquisition is set to “complement” its genomics and multiomics capabilities, broadening its clinical offerings.